文献速递胃肠外科围术期管理与 ERAS

联合内镜-腹腔镜手术(CELS)可避免内镜下不可切除结肠息肉行肠段切除术:10年队列研究

Combined endoscopic-laparoscopic surgery (CELS) can avoid segmental colectomy in endoscopically unremovable colonic polyps: a cohort study over 10 years.
PubMed 文献 · Surg Endosc · 2021-01-13

该观察性研究比较了CELS开展前后腹腔镜治疗内镜下不可切除良性结肠息肉的手术结局。

要点

  • CELS治疗复杂良性结肠息肉安全有效,可避免肠段切除。
  • CELS组并发症显著少于常规腹腔镜肠切除组(p=0.017)。
  • CELS组手术时间和住院时间显著更短,无术后死亡。

核心结论

  • CELS是治疗复杂良性结肠息肉安全有效的方法,通过完全微创腹腔镜途径避免不必要的肠切除吻合。

研究设计与样本

  • 单中心观察性队列研究,回顾2010年1月至2020年2月腹腔镜治疗术前诊断为良性结肠肿瘤的患者病历。

主要发现

  • 组II中位手术时间、住院时间和并发症显著少于组I。
  • 术后并发症共14例(30.4%),多为Clavien-Dindo I-II级(26.1%),组II显著更少(p=0.017);Clavien-Dindo III-IV级两组各1例,无术后死亡。
  • 最终病理显示浸润性腺癌占8.3%,两组无差异;CELS后2例浸润性腺癌患者被建议行肿瘤学切除。

临床怎么用

  • 对于内镜下不可切除的良性结肠息肉,可考虑CELS以避免肠段切除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Combined-Endoscopic-Laparoscopic-Surgery (CELS) was developed for benign colonic polyps, endoscopically unresectable, to avoid segmental colectomy. This observational study aims to compare surgical outcomes of endoscopically unresectable colonic polyps treated laparoscopically before and since the institutional introduction of CELS. Primary endpoint was postoperative morbidity and mortality; secondary endpoints were time of hospitalization and histopathological findings. METHODS: Charts of all patients with preoperative diagnosis of benign colonic tumors, treated laparoscopically at our institution from 1/2010 to 2/2020 were reviewed. Patients with polyps (1) affecting ileocecal valve, (2) occupying > 50% of the circumference, (3) ≥ 3 endoscopically unresectable polyps, (4) inflammatory bowel disease, (5) polyps within diverticular area post diverticulitis, (6) rectal polyps (7) foreseen impossibility of laparoscopy (8) preoperatively biopsy proven invasive adenocarcinoma were excluded. Group I consists of all patients potentially treatable by CELS but operated by laparoscopic colonic resection as CELS was not yet institutionally established. Group II includes all patients treated with CELS (since 11/2017). RESULTS: One hundred-fifteen consecutive patients were reviewed. Applying exclusion criteria, twenty-three patients form group I and twenty-three group II (female 30.4%, median age 68 years). Groups distributed homogenously for age, BMI (body mass index) and polyps´ localization with most polyps (60.4%) localized in right colon; group II patients had significantly higher American Society of Anesthesiologists (ASA) score. Median operating time, hospital stay and morbidity were significantly less in group II. Postoperative morbidity occurred overall in 14 patients (30.4%), mostly Clavien-Dindo class I-II (26.1%) and significantly less in group II (p = 0.017), Clavien-Dindo III-IV distributed equally (one patient each group) without postoperative mortality. Definitive histopathology showed invasive adenocarcinoma in 8.3% without differences between groups. Two patients with invasive adenocarcinoma after CELS were advised for oncological resection. CONCLUSION: CELS is safe and efficient to treat complex, benign colonic polyps by a complete minimal invasive laparoscopic approach. CELS showed better surgical outcomes with less morbidity, no mortality and appropriate pathological results avoiding unnecessary laparoscopic surgery with intestinal anastomosis.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Golda T, Lazzara C, Sorribas M, et al. Combined endoscopic-laparoscopic surgery (CELS) can avoid segmental colectomy in endoscopically unremovable colonic polyps: a cohort study over 10 years. Surg Endosc. 2021. PMID: 33439344. doi:10.1007/s00464-020-08255-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。